A low monthly price does not tell you what happens when you decline treatment, interrupt a plan or try to stop an order. Those are the consequential questions in Mondae’s public documentation. Its homepage promises no charge before physician approval and a starting rate that stays unchanged while membership remains active. Elsewhere, consultation fees are described as nonrefundable even without a prescription, and cancellation closes once medication has been dispensed or shipped.
This review examines Mondae’s enrollment and purchasing terms using public pages consulted October 19, 2026. Mondae documents a telehealth platform offering access to compounded semaglutide, compounded tirzepatide and other treatments through clinicians and outside pharmacies. The central issue is not whether its advertised prices are attractive in isolation. It is whether a prospective patient can identify the applicable price, the services purchased, the ongoing obligation and the practical route out before authorizing payment.
At a glance
- Advertised GLP-1 prices differ
- The homepage lists compounded semaglutide from $69 monthly and compounded tirzepatide from $114 monthly; product pages display $87 and $126 per month, respectively, without clearly mapping those amounts to plan lengths.
- Cash-pay arrangement
- Mondae and its providers say they do not accept commercial insurance or participate in Medicare or Medicaid; patients obtain services outside those programs on a cash-pay basis.Sources: [9]
- Unresolved consultation-charge boundary
- The homepage says no charge occurs before physician approval, while the refund policy makes telehealth consultation fees nonrefundable even when no medication is prescribed.
- Order cancellation cutoff
- An order can be canceled only before medication has been dispensed or shipped. This is separate from any process for ending membership or preventing future charges.Sources: [2]
- Delivery-problem deadline
- Damage or defects must be reported by email within 48 hours of delivery, with photographs of the medication and original packaging. Confirmed problems generally receive replacement first.Sources: [2]
First establish what you are agreeing to buy
Mondae LLC owns and operates the website, but the terms explicitly say Mondae does not provide medical services. They assign medical care to a contracted network of physicians described as licensed in the patient’s state. Another provision says telehealth services are provided by a provider through Bask Telehealth LLC. That division matters: the company presenting a price, the clinician making a treatment decision and the pharmacy dispensing medication have different responsibilities.
The documented enrollment sequence begins with an online questionnaire covering medical history, current medications and treatment goals. A U.S.-licensed healthcare provider then reviews the information and conducts a consultation to decide whether treatment is appropriate. Product pages require a prescription and make prescribing conditional on clinical judgment. Starting an intake therefore is not a promise of medication, and a purchasing agreement should make clear what happens financially if the clinical process stops there.
Mondae also says it neither manufactures medication nor decides which treatment is appropriate. Prescriptions are described as coming from state-licensed U.S. clinicians, with dispensing by licensed U.S. pharmacies. The consulted documentation does not name those pharmacies or independently establish professional licenses. Before enrollment, ask which entity handles each stage and which entity receives payment. Our guide to reading enrollment terms provides a useful framework for separating these obligations.
Resolve the price differences before selecting a plan
Mondae’s homepage and product pages display different prices for the same named offerings. The homepage advertises compounded semaglutide from $69 per month and compounded tirzepatide from $114 per month. Their product pages show $87 and $126 per month alongside one-, three- and six-month plan choices. The consulted text does not clearly associate those displayed product-page amounts with a particular duration or explain how they relate to the lower starting prices.
The discrepancy extends beyond GLP-1 offerings. Sermorelin injection, NAD+ injection and glutathione injection each appear on the homepage from $95, billed monthly. Their individual pages show $99 per month beside one- and three-month choices. These are documented commercial offerings, not evidence that they serve the same clinical purpose. The table preserves the advertised distinctions without assuming a discount, an introductory period or a particular plan-selection setting.
A monthly display does not establish how much is collected at checkout. Nor does a three- or six-month label, by itself, establish medication quantity or a minimum contractual commitment. Mondae’s consulted pages do not settle whether longer options require prepayment, what their total charge is or which supplies and services are included. The practical next step is a written, itemized offer, not multiplying the lowest advertised number by a presumed treatment duration.
| Offering | Homepage advertisement | Product-page display and duration choices |
|---|---|---|
| Compounded semaglutide | From $69/month | $87/month; 1, 3 or 6 months; price-to-plan mapping unclear |
| Compounded tirzepatide | From $114/month | $126/month; 1, 3 or 6 months; price-to-plan mapping unclear |
| Sermorelin injection | From $95, billed monthly | $99/month; 1 or 3 months; price-to-plan mapping unclear |
| NAD+ injection | From $95, billed monthly | $99/month; 1 or 3 months; price-to-plan mapping unclear |
| Glutathione injection | From $95, billed monthly | $99/month; 1 or 3 months; price-to-plan mapping unclear |
The rate promise depends on an undefined membership
Mondae says the starting price remains the same for life as long as membership stays active. It also says the per-month price does not increase when a provider changes the dose. Those are useful commercial representations, but the active-membership condition is material. A person considering a pause needs to know whether that interruption ends the rate protection, how reactivation works and which starting price actually becomes the protected rate.
At the same time, product pages advertise no membership fees, the same price at every dose and one-to-one provider guidance. No membership fee does not necessarily mean no recurring arrangement: a membership can describe access or purchasing status without a separately labeled fee. The documentation does not clearly define that structure. It also does not confirm whether consultations, laboratory work, administration supplies or shipping are included in the displayed amounts.
The consulted terms contain an omitted central portion, limiting review of payment and termination provisions. Renewal mechanics, future charge dates, membership cancellation steps and any advance-notice requirement remain unresolved. These are documentation gaps, not proof that Mondae imposes a particular renewal rule. Before accepting the rate promise, request the complete agreement and distinguish the billing interval from the commitment, as explained in monthly prices and ongoing obligations.
Clarify the consultation charge before authorizing payment
The homepage answers the question of charges when someone does not qualify by saying, “you won’t be charged until a physician approves your treatment.” Read alone, that is a straightforward reassurance about the payment trigger. The refund policy, however, says telehealth consultation fees are nonrefundable, including when medication is not prescribed. The public documentation does not explain how these statements operate together or identify the amount of any consultation fee.
It would be premature to conclude either that every declined applicant pays or that every unsuccessful consultation is free. The statements could concern different charges or stages, but the consulted pages do not establish that distinction. A prospective patient should ask whether a payment authorization differs from a completed charge, whether any consultation charge is separate and which event makes that fee nonrefundable. Obtain that answer before relying on the homepage reassurance.
The insurance position is more explicit. Mondae and its providers say they do not accept commercial health insurance, are not in-network and do not participate in federal or state programs such as Medicare and Medicaid. The terms characterize the transaction as cash-pay outside those arrangements. That makes the actual checkout obligation especially important: neither the advertised monthly figure nor the absence of a membership fee resolves every possible service charge.
Canceling an order is not the same as ending membership
Mondae’s cancellation rule uses an operational cutoff rather than a stated number of hours: orders can be canceled only before medication has been dispensed or shipped. Either event closes the cancellation window. Waiting for tracking information could therefore be too late if dispensing has already occurred. The pages do not provide a dependable interval between clinical approval, dispensing and dispatch, so an assumed cooling-off period would be unsafe to rely on.
For an order successfully canceled before shipping, the policy says a full refund will be issued within five to seven business days. That wording must be read alongside the stricter dispensing-or-shipping cutoff; it does not establish a right to cancel already-dispensed medication. It also does not clearly explain how the full-refund statement interacts with nonrefundable consultation fees. Ask which charges an approved cancellation reverses and request confirmation of the order’s current status.
Stopping one order and stopping future billing are separate tasks. The consulted documentation does not establish a complete membership-exit process or a renewal notice deadline. A cancellation request should explicitly address both the pending order and future commitments, with written confirmation of each outcome. Our guide to order status and cancellation notice explains why a shipment cancellation alone should not be treated as proof that an ongoing arrangement has ended.
Refund reviews and delivery problems have different rules
Outside the successful cancellation provision, Mondae says refunds are not guaranteed and are reviewed only in limited situations. Requests must include the order number, purchase date and a clear explanation; supporting documentation may be required. The stated review period is five to seven business days. If approved, refunds are issued to the original payment method within ten to fourteen business days. Issuance is not a guarantee that the money reaches a bank account within that period.
For damaged or defective medication, the policy requires email notification within 48 hours of delivery and photographs of both the medication and original packaging. If the issue is confirmed, Mondae says it will provide a replacement at no additional cost; a refund is available only if replacement is not possible. An incorrect medication or order follows a similar correction-first approach, with the correct medication shipped without additional charge and return instructions provided if needed.
The policy lists purchase-support hours of 8 a.m. to 8 p.m. Eastern but does not specify days. Its email addresses appear obscured in the consulted documentation, so this review cannot provide a verified usable address. Establish that contact route before purchase, especially given the 48-hour reporting deadline. Keep the distinct cancellation, review and replacement provisions separate; our guide to refund boundaries explains why they should not be combined into one guarantee.
Define the continuing service, not just the shipment
Mondae advertises secure messaging with the healthcare provider through an online patient portal. Patients can raise questions or dose concerns and request follow-up consultations or clinically appropriate adjustments. This documents an ongoing contact channel, but not a scheduled follow-up frequency, a guaranteed response time or a complete fee schedule for additional consultations. One-to-one guidance is more useful as a purchasing term when the patient knows how to access it and what, if anything, costs extra.
If medication is prescribed, Mondae says it ships directly to the patient with tracking information and describes shipping as quick and discreet. Those statements do not set an arrival deadline. The consulted documentation does not establish preparation time, carrier, shipment frequency, cold-chain arrangements or medication quantity per delivery; the shipping-policy content was not available for review. Product concentration, presentation and the specific anatomical administration route also remain unconfirmed, limiting what a buyer can establish from price alone.
The homepage advertises availability in all 50 states, while the terms restrict use to people located in the United States and condition eligibility on the state and service involved. That does not confirm every treatment in every state. Age provisions also need care: terms generally identify age 18 or older, include a parental-consent caveat and note some services may require being over 21. The privacy policy says under-18 accounts are not knowingly allowed; pediatric access is not confirmed.
Privacy and product status belong in the enrollment decision
Mondae’s privacy policy includes an explicit notice that it may sell sensitive personal data, with consent where required. Its terms separately warn that ordinary text messages and emails are not encrypted and may be intercepted. That should be distinguished from the secure portal messaging advertised for treatment communications. Before submitting sensitive information, review the available consent choices and ask which channel should be used for clinical questions, billing documents and photographs accompanying a delivery complaint.
Mondae discloses that compounded medications are not FDA approved and do not undergo FDA review for safety, effectiveness or quality before dispensing. FDA’s guidance likewise distinguishes these preparations from approved products and recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug. Nonapproval alone does not establish clinical inequivalence, nor does a documented contract establish treatment effectiveness. Nothing here independently verifies the quality or outcomes of Mondae’s particular preparations.
FDA also reports errors measuring or administering compounded medication, including some associated with hospitalization. Questions about instructions belong with the prescriber or pharmacist, not a review or a price calculator. For an injectable GLP-1 delivery that arrives warm or insufficiently refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy. That clinical concern is separate from Mondae’s administrative deadline for reporting damage and should not be reduced to a refund question.
Questions & answers
Which semaglutide or tirzepatide price should I budget for?
Mondae displays two sets of prices: homepage starting amounts of $69 and $114 monthly, and product-page amounts of $87 and $126 monthly for compounded semaglutide and tirzepatide, respectively. The consulted text does not resolve the difference or clearly connect the product-page amount to a plan duration. Request the applicable price, initial collection, subsequent charges and included services in writing before paying.
Does choosing six months mean paying for six months upfront?
That is not established. The semaglutide and tirzepatide pages list one-, three- and six-month options, but the consulted text does not explain collection timing, total charges or minimum commitments. A plan-duration label also does not establish the quantity shipped. Ask for both the payment schedule and the consequences of ending the arrangement before the displayed duration has elapsed.
Will I pay anything if the clinician does not prescribe?
The public statements do not settle that question. Mondae’s homepage says there is no charge until physician approval, but its refund policy says consultation fees are nonrefundable even when medication is not prescribed. The consultation fee amount is not established. Ask Mondae to reconcile those statements for your checkout and identify whether any charge can remain after a decision not to prescribe.
Can I cancel after approval but before delivery?
Delivery is not the cutoff. Mondae permits cancellation only before medication has been dispensed or shipped, so an order may already be noncancelable before it arrives or tracking appears. Ask support to confirm dispensing status promptly. Separately request confirmation about membership and future charges, because the documented order-cancellation rule does not establish how to terminate the continuing arrangement.
What if my Mondae order is damaged or incorrect?
For damage or defects, the policy requires an email within 48 hours of delivery with photographs of the medication and original packaging. Confirmed problems receive replacement first, with refunds only when replacement is impossible. Confirmed incorrect orders are corrected without an additional charge. Because the consulted email addresses were obscured, obtain a usable reporting address before ordering rather than waiting until a problem occurs.
Who handles treatment questions after enrollment?
Mondae advertises secure provider messaging through its patient portal, including questions and requests for follow-up consultations or clinically appropriate adjustments. The platform says it does not itself practice medicine. Purchase support has separately advertised hours of 8 a.m. to 8 p.m. Eastern, without stated days. Clinical response times and any additional consultation charges are not established, so clarify both routes before relying on ongoing access.
Our assessment
Mondae documents a recognizable care pathway: intake, clinician review, conditional prescribing, pharmacy dispensing, home shipment and portal follow-up. It also publishes meaningful cancellation and delivery-problem rules rather than leaving every after-purchase issue unaddressed. Its cash-pay position and dose-independent pricing promise are useful disclosures. The weaknesses sit at the points where a patient must authorize or stop spending: differing advertised prices, unclear plan-to-price mapping, an undefined active membership and unresolved consultation-charge language. The consulted terms were also incomplete, preventing a full assessment of payment and termination provisions. Before enrolling, obtain a written offer identifying the exact product, total initial charge, recurring obligations, included services, consultation-fee boundary and separate procedures for canceling an order and ending membership. Mondae’s public documentation supports further inquiry, but not treating the headline monthly price as a complete purchasing agreement.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- Mondae — policies/refunds ↗
- Mondae — official website ↗
- Mondae — treatments/compounded tirzepatide ↗
- Mondae — treatments/glutathione ↗
- Mondae — treatments/nad ↗
- Mondae — policies/privacy policy ↗
- Mondae — treatments/compounded semaglutide ↗
- Mondae — policies/terms of service ↗
- Mondae — treatments/sermorelin ↗